Trial intelligence / Profile preview

Erythrocyte-bound apolipoprotein B after statin withdrawal

NL-OMON38118Active, not recruiting

Sponsor
Franciscus Gasthuis & Vlietland
Start
Jul 2012
Countries
1
01

Overview

Open-label, single-arm trial in hypercholesterolemia, sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Erythrocyte-bound apolipoprotein B. Started Jul 2012; status: active, not recruiting.

02

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NL-OMON38118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call